Patents by Inventor Alessandro PALUMBO

Alessandro PALUMBO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939383
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4. The anti-B7-H4 antibodies or antigen-binding fragments thereof are useful, for example in detecting B7-H4. Immunohistochemistry (IHC) can be used to detect B7-H4. The present disclosure also provides methods for treating cancer wherein increased B7-H4 has been detected, by administering a therapeutic anti-B7-H4 antibody or antigen-binding fragment thereof.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: March 26, 2024
    Assignee: FIVE PRIME THERAPEUTICS, INC.
    Inventors: Charles Kaplan, Alessandro Palumbo, Kathy Miller, Hangil Park, Nerissa Mendoza, Majid Ghoddusi
  • Publication number: 20230416382
    Abstract: This present invention provides anti-C—C chemokine type 8 (CCR8) antibodies and antigen binding fragments thereof, methods of making the antibodies or antigen binding fragments thereof, and methods of use thereof to bind to human CCR8 on CCR8 expressing cells, e.g., tumor-infiltrating Treg cells, to remove CCR8 expressing cells, e.g, tumor-infiltrating Treg cells, to reduce or inhibit tumor growth and/or to treat cancer.
    Type: Application
    Filed: October 13, 2021
    Publication date: December 28, 2023
    Applicant: Five Prime Therapeutics, Inc.
    Inventors: Susannah D. BARBEE, Shujun YUAN, Marcel MEURY, Alessandro PALUMBO, Terence WONG, Kathrin ZUBERBUHLER, Emilia FALKOWSKA
  • Publication number: 20220386660
    Abstract: The present invention relates to use of enzymes having alpha-amylase activity for obtaining a hydrolysed oat material.
    Type: Application
    Filed: November 19, 2020
    Publication date: December 8, 2022
    Applicant: Novozymes A/S
    Inventors: Benjamin Thieringer, Alessandro Palumbo
  • Publication number: 20210079096
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4. The anti-B7-H4 antibodies or antigen-binding fragments thereof are useful, for example in detecting B7-H4. Immunohistochemistry (IHC) can be used to detect B7-H4 The present disclosure also provides methods for treating cancer wherein increased B7-H4 has been detected, by administering a therapeutic anti-B7-H4 antibody or antigen-binding fragment thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: March 18, 2021
    Inventors: Charles KAPLAN, Alessandro PALUMBO, Kathy MILLER, Hangil PARK, Nerissa MENDOZA, Majid GHODDUSI